(Q44093845)

English

Regulatory decisions in a globalised world: the domino effect of phenylpropanolamine withdrawal in Latin America

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Regulatory decisions in a globalised world: the domino effect of phenylpropanolamine withdrawal in Latin America (English)

1 reference

Europe PubMed Central

29 November 2017

Albert Figueras

1

1 reference

Europe PubMed Central

29 November 2017

author name string

Joan-Ramon Laporte

2

1 reference

Europe PubMed Central

29 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

25

1 reference

Europe PubMed Central

29 November 2017

10

1 reference

Europe PubMed Central

29 November 2017

689-693

1 reference

Europe PubMed Central

29 November 2017

https://scigraph.springernature.com/pub.10.2165/00002018-200225100-00001

0 references

Stroke and phenylpropanolamine use

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenylpropanolamine and other OTC alpha-adrenergic agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PHENYLPROPANOLAMINE AND CEREBRAL HAEMORRHAGE

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenylpropanolamine in drugs could be a risk for stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hazards of the appetite suppressant phenylpropanolamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The FDA, regulation, and the risk of stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology. Adverse reactions to drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of automated databases for pharmacoepidemiology research

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenylpropanolamine and the risk of hemorrhagic stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/12167064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200225100-00001

1 reference

Europe PubMed Central

29 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44093845&oldid=2106530521"